Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan
Open Access
- 7 June 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 17 (6), e1009619
- https://doi.org/10.1371/journal.ppat.1009619
Abstract
We aimed to investigate novel emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages in Japan that harbor variants in the spike protein receptor-binding domain (RBD). The total nucleic acid contents of samples from 159 patients with coronavirus disease 2019 (COVID-19) were subjected to whole genome sequencing. The SARS-CoV-2 genome sequences from these patients were examined for variants in spike protein RBD. In January 2021, three family members (one aged in their 40s and two aged under 10 years old) were found to be infected with SARS-CoV-2 harboring W152L/E484K/G769V mutations. These three patients were living in Japan and had no history of traveling abroad. After identifying these cases, we developed a TaqMan assay to screen for the above hallmark mutations and identified an additional 14 patients with the same mutations. The associated virus strain was classified into the GR clade (Global Initiative on Sharing Avian Influenza Data [GISAID]), 20B clade (Nextstrain), and R.1 lineage (Phylogenetic Assignment of Named Global Outbreak [PANGO] Lineages). As of April 22, 2021, R.1 lineage SARS-CoV-2 has been identified in 2,388 SARS-CoV-2 entries in the GISAID database, many of which were from Japan (38.2%; 913/2,388) and the United States (47.1%; 1,125/2,388). Compared with that in the United States, the percentage of SARS-CoV-2 isolates belonging to the R.1 lineage in Japan increased more rapidly over the period from October 24, 2020 to April 18, 2021. R.1 lineage SARS-CoV-2 has potential escape mutations in the spike protein RBD (E484K) and N-terminal domain (W152L); therefore, it will be necessary to continue to monitor the R.1 lineage as it spreads around the world. A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in Wuhan, China. SARS-CoV-2 had evolved and spread around the world, threatening human life. Several mutations, which alter the viral fitness, virulence, and transmissibility, were identified in SARS-CoV-2. Here, we detected R.1 lineage SARS-CoV-2 harboring mutations in spike protein. The R.1 lineage have spread at the beginning of 2021 in Japan. This lineage has potential escape mutations in the spike protein receptor-binding domain (E484K) and N-terminal domain (W152L). We also developed a novel TaqMan assay targeting the hallmark mutations occurring in the spike proteins of R.1 lineage for screening. Our data indicate that emergent variants are dominated by the natural selection and need to be monitored by genomic epidemiological research.Keywords
Funding Information
- Yamanashi Prefecture (Grant-in-Aid for the Genome Research Project)
- Yamanashi Prefecture (Grant-in-Aid for the Genome Research Project)
- Japan Society for the Promotion of Science (KAKENHI Early-Career Scientists JP18K16292)
- Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (B) 20H03668)
- Japan Society for the Promotion of Science (Research Grant for Young Scholars)
- Yasuda Medical Foundation
- Uehara Memorial Foundation
- Takeda Science Foundation (Medical Research Grants)
This publication has 39 references indexed in Scilit:
- Spike mutation D614G alters SARS-CoV-2 fitnessNature, 2020
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Science, 2020
- Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in JapanJapanese Journal of Infectious Diseases, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020
- Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assayJournal of Virological Methods, 2020
- Environmental cleaning is effective for the eradication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in contaminated hospital rooms: A patient from the Diamond Princess cruise shipInfection Control & Hospital Epidemiology, 2020
- Nextstrain: real-time tracking of pathogen evolutionBioinformatics, 2018
- GISAID: Global initiative on sharing all influenza data – from vision to realityEurosurveillance, 2017
- Viral deep sequencing needs an adaptive approach: IRMA, the iterative refinement meta-assemblerBMC Genomics, 2016
- A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal diseaseNature Medicine, 2012